Related Experiment Video
Updated: Apr 27, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
In vitro evaluation of fluorescence glucose biosensor response
Mamdouh Aloraefy1, T Joshua Pfefer2, Jessica C Ramella-Roman3
1Center for Devices and Radiological Health, Food and Drug Administration, Silver Spring, MD 20993, USA. Mamdouh.Aloraefy@fda.hhs.gov.
This study presents standardized in vitro testing methods for Förster Resonance Energy Transfer (FRET) glucose biosensors. These methods enable rigorous evaluation of FRET biosensor performance for improved diabetes management.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Diabetes Technology
Background:
- Accurate glucose monitoring is crucial for diabetes management.
- Förster Resonance Energy Transfer (FRET) biosensors offer potential for rapid, minimally-invasive glucose measurement.
- Standardized in vitro evaluation methods are needed to advance optical glucose biosensor technology.
Purpose of the Study:
- To establish a comprehensive set of in vitro test methods for evaluating optical glucose biosensor performance.
- To fabricate and characterize Förster Resonance Energy Transfer (FRET)-based glucose biosensors using the developed methods.
- To provide a foundation for future consensus standards in FRET glucose biosensor evaluation.
Main Methods:
- Fabrication of FRET-based glucose biosensors utilizing competitive binding and long-wavelength fluorescence dye pairs.
- Implementation of standardized in vitro testing for spectral response, linearity, sensitivity, limit of detection, kinetics, reversibility, stability, precision, and accuracy.
- Characterization of biosensor performance against established metrics.
Main Results:
- The FRET biosensor exhibited a 45% fluorescence change with 400 mg/dL glucose.
- Demonstrated a limit of detection of 25 mg/dL and a response time of 15 minutes.
- Showcased a mean absolute relative difference < 11% and a 72% fluorescence decay over 30 days.
Conclusions:
- The developed battery of tests provides objective, quantitative in vitro evaluation of FRET glucose biosensor performance.
- These methods facilitate thorough assessment of biosensor strengths and weaknesses, aiding technological innovation.
- The proposed testing framework has the potential to become a basis for future consensus standards in glucose biosensor development.
More Related Videos
10:35Extracellular Glucose Depletion as an Indirect Measure of Glucose Uptake in Cells and Tissues Ex Vivo
Published on: April 6, 2022
13:42Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
Published on: September 19, 2017